SEC Comment Letter 0000000000-23-010939 to TC BioPharm (Holdings) plc (TCBP, TCBPW) (CIK 0001872812) (TCBPY)
TC BioPharm (Holdings) plc (TCBP, TCBPW) (CIK 0001872812)
Date: Oct. 4, 2023 · CIK: 0001872812 · Accession: 0000000000-23-010939
AI Filing Summary & Sentiment
File numbers found in text: 333-274778
Letter
United States securities and exchange commission logo October 4, 2023 Bryan Kobel Chief Executive Officer TC BioPharm (Holdings) plc Maxim 1, 2 Parklands Way Holytown, Motherwell, ML1 4WR Scotland, United Kingdom Re:TC BioPharm (Holdings) plc Registration Statement on Form F-3 Filed September 29, 2023 File No. 333-274778 Dear Bryan Kobel: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
October 4, 2023
Bryan Kobel
Chief Executive Officer
TC BioPharm (Holdings) plc
Maxim 1, 2 Parklands Way
Holytown, Motherwell, ML1 4WR
Scotland, United Kingdom
Re:TC BioPharm (Holdings) plc
Registration Statement on Form F-3
Filed September 29, 2023
File No. 333-274778
Dear Bryan Kobel:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences